Search Results - C. Row
- Showing 1 - 2 results of 2
-
1
856 | MARSUN, A PHASE III, MULTICENTER, OPEN LABEL, RANDOMIZED STUDY INVESTIGATING MOSUNETUZUMAB‐LENALIDOMIDE VERSUS INVESTIGATOR CHOICES IN R/R MARGINAL ZONE LYMPHOMAS by S. Carras, G. Cartron, F. Morcshhauser, A. Conconni, C. Buske, S. Luminari, M. Dreyling, M. Gomes Da Silva, M. André, C. Row, E. Gehlkopf, C. Thieblemont
Published 2025Get full text
Artículo Open Access -
2
254 | RITUXIMAB AND IBRUTINIB COMBINATION IN UNTREATED SMZL AND NMZL: LONG‐TERM OUTCOME AND THE IMPACT OF EARLY MINIMAL RESIDUAL DISEASE FROM THE IELSG47/MALIBU PHASE II STUDY by C. Thieblemont, C. Row, T. Lamy, R. Aucagne, M. Tani, M. Merli, M. Deodato, S. V. Usai, C. Minoia, C. Bommier, C. Fournier, F. Bijou, M. C. Pirosa, A. Anastasia, L. Devizzi, S. Luminari, L. Arcaini, S. Chevreux, R. Gressin, M. André, N. Ielmini, L. Bonomini, E. Zucca, M. Callanan, A. Conconi
Published 2025Get full text
Artículo Open Access